Literature DB >> 25815155

Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT2C Receptor Agonists.

Guy Rouquet1, Dianna E Moore2, Malcolm Spain3, Daniel M Allwood1, Claudio Battilocchio1, David C Blakemore3, Paul V Fish3, Stephen Jenkinson4, Alan S Jessiman3, Steven V Ley1, Gordon McMurray3, R Ian Storer3.   

Abstract

A series of pyrido[3,4-d]azepines that are potent and selective 5-HT2C receptor agonists is disclosed. Compound 7 (PF-04781340) is identified as a suitable lead owing to good 5-HT2C potency, selectivity over 5-HT2B agonism, and in vitro ADME properties commensurate with an orally available and CNS penetrant profile. The synthesis of a novel bicyclic tetrasubstituted pyridine core template is outlined, including rationale to account for the unexpected formation of aminopyridine 13 resulting from an ammonia cascade cyclization.

Entities:  

Keywords:  5-HT2C receptor agonist; CNS penetration; Tetrasubstituted pyridines; pyrido[3,4-d]azepine

Year:  2015        PMID: 25815155      PMCID: PMC4360148          DOI: 10.1021/ml500507v

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  20 in total

1.  Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity.

Authors:  Kevin K-C Liu; Bruce A Lefker; Mark A Dombroski; Phoebe Chiang; Peter Cornelius; Terrell A Patterson; Yuan Zeng; Stephanie Santucci; Elizabeth Tomlinson; Colleen P Gibbons; Ravi Marala; Janice A Brown; Jimmy X Kong; Eunsun Lee; Wendy Werner; Zane Wenzel; Craig Giragossian; Hou Chen; Steven B Coffey
Journal:  Bioorg Med Chem Lett       Date:  2010-01-25       Impact factor: 2.823

2.  Synthesis of 1-aminoisoquinolines by gold(III)-mediated domino reactions from 2-alkynylbenzamides and ammonium acetate.

Authors:  Yuhua Long; Zhigang She; Xiaochen Liu; Yu Chen
Journal:  J Org Chem       Date:  2013-03-01       Impact factor: 4.354

Review 3.  New obesity agents: lorcaserin and phentermine/topiramate.

Authors:  Joshua W Fleming; Katie S McClendon; Daniel M Riche
Journal:  Ann Pharmacother       Date:  2013-06-25       Impact factor: 3.154

Review 4.  Targeting 5-HT receptors for the treatment of obesity.

Authors:  Bruce J Sargent; Alan J Henderson
Journal:  Curr Opin Pharmacol       Date:  2011-02-15       Impact factor: 5.547

5.  A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein.

Authors:  Julie E Penzotti; Michelle L Lamb; Erik Evensen; Peter D J Grootenhuis
Journal:  J Med Chem       Date:  2002-04-25       Impact factor: 7.446

6.  Novel pyrimidoazepine analogs as serotonin 5-HT(2A) and 5-HT(2C) receptor ligands for the treatment of obesity.

Authors:  Ha Yun Yang; Jinsung Tae; Yong Wan Seo; Yoon Jung Kim; Hye Yeon Im; Gil Don Choi; Heeyeong Cho; Woo-Kyu Park; Oh Seung Kwon; Yong Seo Cho; Minkyung Ko; HyunSeo Jang; Jaeick Lee; Kihang Choi; Chan-Hwa Kim; Jiyoun Lee; Ae Nim Pae
Journal:  Eur J Med Chem       Date:  2013-02-27       Impact factor: 6.514

7.  Design, synthesis, and pharmacology of fluorescently labeled analogs of serotonin: application to screening of the 5-HT2C receptor.

Authors:  Peter Cornelius; Eunsun Lee; Wen Lin; Ruduan Wang; Wendy Werner; Janice A Brown; Frank Stuhmeier; James G Boyd; Kim McClure
Journal:  J Biomol Screen       Date:  2009-04

8.  Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence.

Authors:  Paul E Brennan; Gavin A Whitlock; Danny K H Ho; Kelly Conlon; Gordon McMurray
Journal:  Bioorg Med Chem Lett       Date:  2009-07-16       Impact factor: 2.823

9.  Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptors.

Authors:  R Ian Storer; Paul E Brennan; Alan D Brown; Peter J Bungay; Kelly M Conlon; Matthew S Corbett; Robert P DePianta; Paul V Fish; Alexander Heifetz; Danny K H Ho; Alan S Jessiman; Gordon McMurray; Cesar Augusto F de Oliveira; Lee R Roberts; James A Root; Veerabahu Shanmugasundaram; Michael J Shapiro; Melanie Skerten; Dominique Westbrook; Simon Wheeler; Gavin A Whitlock; John Wright
Journal:  J Med Chem       Date:  2014-06-17       Impact factor: 7.446

Review 10.  Agonists of the serotonin 5-HT2C receptor: preclinical and clinical progression in multiple diseases.

Authors:  Dean A Wacker; Keith J Miller
Journal:  Curr Opin Drug Discov Devel       Date:  2008-07
View more
  1 in total

1.  Synthesis and Biological Evaluation of Disubstituted Pyrimidines as Selective 5-HT2C Agonists.

Authors:  Juhyeon Kim; Yoon Jung Kim; Ashwini M Londhe; Ae Nim Pae; Hyunah Choo; Hak Joong Kim; Sun-Joon Min
Journal:  Molecules       Date:  2019-09-05       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.